It was close to evening and Barbara’s Place was nearly empty – only clusters of students filled the seats. One group that hung out at a table outside was happy to talk about sexual health – in general. The students got quieter, however, when asked if they would share their STD status on the Internet.
During the sexually transmitted disease prevention conference in Chicago on March 11, the U.S. Centers for Disease Control and Prevention announced an alarming finding.
Recently the Food and Drug Administration approved a vaccine to prevent the Human Papillomavirus, the sexually transmitted virus that causes cervical cancer among other things. The vaccine is called Gardasil.
A vaccine that could prevent a common form of cancer has been found, but its pricetag could be prohibitive to the population that needs it most – college–age women.